Endoscopic Management of Bile Leakage after Liver Transplantation.
- Author:
Dongwook OH
1
;
Sung Koo LEE
;
Tae Jun SONG
;
Do Hyun PARK
;
Sang Soo LEE
;
Dong Wan SEO
;
Myung Hwan KIM
Author Information
- Publication Type:Original Article ; Evaluation Studies
- Keywords: Cholangiopancreatography, endoscopic retrograde; Bile leakage; Liver transplantation
- MeSH: Adult; Anastomotic Leak/etiology/*surgery; *Bile; Biliary Tract Diseases/etiology/*surgery; Cholangiopancreatography, Endoscopic Retrograde/*methods; Constriction, Pathologic/therapy; Drainage; Female; Humans; *Liver Transplantation; Male; Middle Aged; Stents; Treatment Outcome; Young Adult
- From:Gut and Liver 2015;9(3):417-423
- CountryRepublic of Korea
- Language:English
- Abstract: BACKGROUND/AIMS: Endoscopic retrograde cholangiopancreatography (ERCP) can be an effective treatment for bile leakage after liver transplantation. We evaluated the efficacy of endoscopic treatment in liver transplantation in patients who developed bile leaks. METHODS: Forty-two patients who developed bile leaks after liver transplantation were included in the study. If a bile leak was observed on ERCP, a sphincterotomy was performed, and a nasobiliary catheter was then inserted. If a bile leak was accompanied by a bile duct stricture, either the stricture was dilated with balloons, followed by nasobiliary catheter insertion across the bile duct stricture, or endoscopic retrograde biliary drainage was performed. RESULTS: In the bile leakage alone group (22 patients), endoscopic treatment was technically successful in 19 (86.4%) and clinically successful in 17 (77.3%) cases. Among the 20 patients with bile leaks with bile duct strictures, endoscopic treatment was technically successful in 13 (65.0%) and clinically successful in 10 (50.0%) cases. Among the 42 patients who underwent ERCP, technical success was achieved in 32 (76.2%) cases and clinical success was achieved in 27 (64.3%) cases. CONCLUSIONS: ERCP is an effective and safe therapeutic modality for bile leaks after liver transplantation. ERCP should be considered as an initial therapeutic modality in post-liver transplantation patients.
